On Tuesday, Shares of Pain Therapeutics Inc. (NASDAQ:PTIE), skyrocketed 35.05% to $2.62.
Pain Therapeutics, declared top-line results of an FDA Category 3 Human Abuse Potential Study with REMOXY Extended-Release Capsules CII, its lead drug candidate that is specifically designed to discourage certain common methods of drug tampering and misuse. This study demonstrated with statistical significance (p<0.0001) that both intact and chewed REMOXY were less “liked” than immediate-release oxycodone on the two primary endpoints, Drug Liking and Drug High. The Abuse Potential study was conducted in non-dependent, recreational opioid users, as recommended by FDA guidelines.
“We believe today’s results demonstrate abuse-deterrent properties of the REMOXY formulation against a common, and often lethal, form of oral drug abuse,” said Nadav Friedmann, PhD, MD., Pain Therapeutics’ Chief Medical Officer.
Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs in the United States. The company’s lead drug candidate is REMOXY, an extended-release oral formulation of oxycodone for the administration of moderate-to-severe pain when a continuous and around-the-clock opioid analgesic is needed.
Shares of JetBlue Airways Corporation (NASDAQ:JBLU), declined -0.55% to $21.71, during its last trading session.
JetBlue Airways Corporation, stated its preliminary traffic results for April 2015. Traffic in April raised 9.0 percent from April 2014, on a capacity enhance of 6.6 percent. Load factor for April 2015 was 85.7 percent, an enhance of 1.8 points from April 2014. JetBlue’s preliminary completion factor was 99.4 percent and its on-time (1) performance was 80.4 percent. JetBlue’s preliminary passenger revenue per accessible seat mile (PRASM) for the month of April raised about four percent year over year.
JetBlue Airways Corporation, a passenger carrier company, provides air transportation services. As of December 31, 2014, the company operated a fleet of 13 Airbus A321 aircrafts, 130 Airbus A320 aircrafts, and 60 EMBRAER 190 aircrafts.
At the end of Tuesday’s trade, Shares of Penn Virginia Corporation (NYSE:PVA), lost -3.29% to $5.29.
Penn Virginia Corporation, declared that it convened its annual meeting of shareholders on Thursday, May 7, 2015 and adjourned the meeting due to lack of requisite votes with respect to the proposal to amend its Articles of Incorporation to enhance the number of authorized shares of common stock. The annual meeting will reconvene on May 13, 2015 to allow the Company’s shareholders additional time to vote.
Penn Virginia Corporation, an independent oil and gas company, explores, develops, and produces crude oil, natural gas liquids, and natural gas in various onshore regions of the United States. The company’s operations comprise the drilling of unconventional horizontal development wells in the Eagle Ford Shale in South Texas.
Finally, E. I. du Pont de Nemours and Company (NYSE:DD), ended its last trade with -0.73% gain, and closed at $74.36.
The Chemours Company, a wholly owned partner of Du Pont, and Company, declared the completion of certain financing transactions in connection with DuPont’s formerly declared projected pro rata distribution of Chemours common stock to holders of DuPont common stock, subject to customary closing conditions.
Chemours accomplished an offering of its $1,350 million 6.625 percent senior notes due 2023, $750 million 7.000 percent senior notes due 2025 and €360 million 6.125 percent senior notes due 2023. Chemours also reached a credit agreement with a syndicate of banks providing for a seven-year $1.5 billion senior secured Term Loan B Facility and a five-year $1.0 billion senior secured Revolving Credit Facility. Chemours used the proceeds from the financing transactions to fund a distribution to DuPont of about $3.9 billion, in recognition of the assets contributed to it by DuPont in anticipation of the Separation.
E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. The company’s Agriculture segment offers corn hybrid, soybean, canola, sunflower, sorghum, inoculants, seed products, wheat, rice, herbicides, fungicides, and insecticides. Its Electronics & Communications segment provides various materials and systems, counting photopolymers and electronic materials for photovoltaic products, consumer electronics, displays, and advanced printing.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
